ROS also promotes HuR (human antigen R), NF-κB, and AP-1 nucleus translocation to increase uPA (urokinase-type plasminogen activator) and uPAR (urokinase-type plasminogen activator receptor) expression, degrading extracellular matrix to facilitate tumor cell metastases. Here, ELAVL1 is linked to neoplasm.